Venrock Healthcare Capital Partners
34 portfolio companies · 6 on the map · $2.1B raised · 4 cities
Portfolio map
6 Venrock Healthcare Capital Partners portfolio companies on the map.
Portfolio companies

Ocular Therapeutix
Bedford
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Pharmaceutical Manufacturing$1.2BEst. 2006
Mineralys Therapeutics
Radnor
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Biotechnology Research$740.5MEst. 2020Hiring fast
Artiva Biotherapeutics
San Diego
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Biotechnology Research$198MEst. 2019
ADARx Pharmaceuticals
San Diego
ADARx Pharmaceuticals, Inc., a San Diego-based clinical-stage biotechnology company, develops RNA-targeting platforms and oligonucleotide delivery technologies to inhibit, degrade, or edit disease-causing mRNA, pursuing programs across gene
BiotechnologyEst. 2019Tenaya Therapeutics
South San Francisco
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Biotechnology ResearchPublicEst. 2016
Lycia Therapeutics
South San Francisco
Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise
BiotechnologySeries CEst. 2020
More portfolio companies
27 more Venrock Healthcare Capital Partners investments we track beyond the map — 34 tracked in total.
TubulisMunich · Series C
Maze TherapeuticsSouth San Francisco · Post-IPO Equity
Apogee TherapeuticsSan Francisco · Series B
Oruka TherapeuticsWaltham · Post-IPO Equity
enGeneVancouver · Post-IPO Equity
AbivaxParis · Post-IPO Equity
Terns PharmaceuticalsFoster City · Post-IPO Equity
Korro BioCambridge · Post-IPO Equity
Dianthus TherapeuticsWaltham · Post-IPO Equity
Angitia BiopharmaceuticalsWestlake Village · Series D
Upstream BioWaltham · Series B
Enliven TherapeuticsBoulder · Post-IPO Equity
AIRNACambridge · Series B
Centessa PharmaceuticalsCambridge · Series A
Carmot TherapeuticsBerkeley · Series E
ORIC PharmaceuticalsSouth San Francisco · Post-IPO Equity
Cidara TherapeuticsSan Diego · Post-IPO Equity
SurrozenSouth San Francisco · Post-IPO Equity
Lyra TherapeuticsWatertown · Post-IPO Equity
Avadel PharmaceuticalsDublin · Post-IPO Equity
LianBioShanghai · Series A
Cullinan TherapeuticsCambridge · Post-IPO Equity
Taysha Gene TherapiesDallas · Post-IPO Equity
PharvarisZug · Post-IPO Equity
Kiniksa PharmaceuticalsHamilton · Series C
CASI PharmaceuticalsRockville · Post-IPO Equity
Surface OncologyCambridge · Post-IPO Equity
Portfolio map
6 Venrock Healthcare Capital Partners portfolio companies on the map.